Institutional investors purchased a net $6.4 million shares of OPK during the quarter ended December 2013. This may signal that the smart money is gaining interest in this company as the 17.30% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EDGE WEALTH MANAGEMENT LLC Bought 3.0 Thousand shares of OPKO Health Inc
CREATIVE PLANNING, INC. Bought 350.00 shares of OPKO Health Inc
JOEL ISAACSON & CO. LLC Sold 14.0 Thousand shares of OPKO Health Inc